Edwards SAPIEN XT Transcatheter Aortic Heart Valve
Also known as:
PARTNER II clinical trial, SAPIEN XT
The PARTNER II Clinical Trial is designed to investigate the next generation transcatheter aortic valve, the Edwards SAPIEN XT, in both intermediate and high-surgical risk patients, as well as inoperable patients. Learn more about qualification for this clinical trial.
Providence Valve Center remains at the forefront of treating advanced heart disease and is the highest-volume site in Oregon to offer the revolutionary Sapien aortic valve replacement procedure.